Holen Sie sich die Stockscreener-App
43.80
0.60%
0.26
Handel nachbörslich:
43.83
0.03
+0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten
Kardigan raises $254M to test cardio drugs from Sanofi, BMS and Ionis - Endpoints News
11 Years of Global Patient Week: Bristol Myers Squibb Brings Joy to Patients with Toy-Making Workshops Across the Region - PR Newswire UK
Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn - European Pharmaceutical Review
What Bristol-Myers Squibb (BMY)'s FDA Fast Track for Alzheimer’s Drug Means for Shareholders - simplywall.st
Bristol Myers' $1.5 Billion RNA Gamble: Could Orbital Therapeutics Rewire Its Future? - Smartkarma
What to Expect From Bristol-Myers Squibb's Next Quarterly Earnings Report - inkl
Bristol-Myers Squibb (BMY): Strong Growth Pipeline Supports High-Yield Dividend - Yahoo Finance
Why Top Investors Are Buying Bristol-Myers Squibb Co (BMY) - The Acquirer's Multiple
Pharma companies announce direct-to-consumer sales and price cuts in US - Reuters
Bristol Myers Faces Legacy Headwinds But Banks On Its Pipeline - Finimize
Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight - GlobeNewswire Inc.
Bispecifics in Oncology Market Statistics Expected to Experience Major Growth by 2040, According to DelveInsight | AstraZeneca, I-MAB Biopharm, BioNTech, Bristol Myers Squibb - Barchart.com
Trend analysis for Bristol Myers Squibb Company this weekJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration - BioSpace
Mark Cuban’s Pharmacy Targets Drug Pricing Reform as AstraZeneca Invests $4.5 Billion in Virginia and Bristol Myers Squibb Acquires Orbital Therapeutics for $1.5 Billion - geneonline.com
Stock Looks Undervalued As Bristol Myers Buys Orbital Therapeutics (NYSE:BMY) - Seeking Alpha
Bristol Myers (BMY) Triggers Milestone Payment with SystImmune C - GuruFocus
SystImmune receives $250 million milestone payment from Bristol Myers Squibb - Investing.com
Covington aids Bristol Myers Squibb on Orbital Therapeutics acquisition - ICLG.com
Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus - Seeking Alpha
Bristol-Myers Squibb (BMY): Exploring Valuation After Recent Share Price Declines - simplywall.st
Bristol Myers Squibb: Value Emerges From Distress - Seeking Alpha
Bristol Myers Squibb’s Alzheimer’s Drug, BMS-986446, Granted FDA Fast Track Status - Yahoo Finance
Conning Inc. Has $33.17 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Fourpath Capital Management LLC Trims Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
CAR Ts for autoimmune ramp up: BMS buying Orbital for $1.5B - BioWorld MedTech
BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology
Bristol Myers to buy Cambridge startup Orbital Therapeutics, building out cell therapy pipeline - The Boston Globe
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push | Business Information & News | FE - Westlaw Today
What's Going On With Bristol Myers Squibb Stock Friday?Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Acquisition - GuruFocus
Chart based analysis of Bristol Myers Squibb Company trendsEntry Point & Fast Moving Market Watchlists - newser.com
Bristol Myers Squibb buys Cambridge biotech for $1.5B - The Business Journals
BMS latest to enter in vivo CAR-T field with $1.5B Orbital buy - FirstWord Pharma
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push - Reuters
Bristol Myers Squibb To Acquire Orbital Therapeutics - citybiz
Bristol Myers makes $1.5B bid for Orbital Therapeutics - The Pharma Letter
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push By Reuters - Investing.com
Bristol Myers (BMY) to Acquire Orbital Therapeutics in $1.5 Bill - GuruFocus
Bristol Myers Squibb (BMY) Expands with Orbital Therapeutics Acq - GuruFocus
Bristol Myers Squibb to acquire Orbital for $1.5B - NJBIZ
Bristol Myers Squibb to acquire Orbital Therapeutics for $1.5 billion - Investing.com
$1.5B deal: Bristol Myers Squibb acquires Orbital, gaining OTX-201 and RNA in vivo CAR T platform - Stock Titan
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection – Company AnnouncementFT.com - Financial Times
Blair William & Co. IL Sells 222,590 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb: Your Chance To Buy A Bargain 6% Yield (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb Company $BMY Shares Sold by Vontobel Holding Ltd. - MarketBeat
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term - Yahoo Finance
Abel Hall LLC Has $444,000 Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Shell Asset Management Co. Raises Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Kingswood Wealth Advisors LLC - MarketBeat
Pharmaceutical research and development pipeline - Bristol Myers Squibb
Cell Therapy Market Set for Dynamic Growth with Key Players Bristol Myers Squibb Company, Amgen Inc. - industrytoday.co.uk
Bristol Myers Squibb 2025: Rewiring the company - PharmaLive
Bristol Myers Squibb Company $BMY Shares Sold by Grimes & Company Inc. - MarketBeat
Ameriflex Group Inc. Lowers Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks - Yahoo
Alta Wealth Advisors LLC Has $462,000 Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by QRG Capital Management Inc. - MarketBeat
Bristol Myers Squibb Stock Hits Day High with Strong Intraday Performance - Markets Mojo
Fairvoy Private Wealth LLC Sells 18,895 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by J. Safra Sarasin Holding AG - MarketBeat
New Century Financial Group LLC Acquires New Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Quattro Financial Advisors LLC Sells 19,600 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Hudson Edge Investment Partners Inc. Acquires 17,191 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
0.78%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):